Enanta Pharmaceuticals
ENTA
#8287
Rank
โ‚น30.61 B
Marketcap
โ‚น1,051
Share price
-2.18%
Change (1 day)
2.95%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -โ‚น4.61 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น65.25 Million. In 2025 the company made an earning of -โ‚น6 Billion, an increase over its 2024 earnings that were of -โ‚น9.09 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น4.61 Billion-23.09%
2025 -โ‚น6 Billion-34.07%
2024 -โ‚น9.09 Billion-23.87%
2023 -โ‚น11.94 Billion4.39%
2022 -โ‚น11.44 Billion-4.4%
2021 -โ‚น11.97 Billion91.12%
2020 -โ‚น6.26 Billion-407.13%
2019 โ‚น2.03 B-78.63%
2018 โ‚น9.53 B117.97%
2017 โ‚น4.37 B-574.65%
2016 -โ‚น0.93 Billion-110.83%
2015 โ‚น8.51 B-4.5%
2014 โ‚น8.91 B-638.53%
2013 -โ‚น1.66 Billion-137.98%
2012 โ‚น4.35 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น1.753 T-37,381.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.184 T-25,277.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
โ‚น1.200 T-25,618.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น427.29 B-9,183.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น629.81 B-13,488.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.061 T-22,666.96%๐Ÿ‡บ๐Ÿ‡ธ USA